Arvinas, Inc. (ARVN) stock
ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.76−0.06 (-0.81%)
Close on Nov 18, 2026Market cap $442.34MP/E 42.3Yield –
Arvinas market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Arvinas's market cap was $451.22M on Nov 11, 2026, against $891.02M a year earlier. Over the last 5 years it ranged from $451.22M to $4.33B, with a median of $1.39B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $451.22M | -46.3% |
| 2025 | Dec 31, 2025 | $839.69M | -36.2% |
| 2024 | Dec 31, 2024 | $1.32B | -41.8% |
| 2023 | Dec 29, 2023 | $2.26B | +24.4% |
| 2022 | Dec 30, 2022 | $1.82B | -58.0% |
| 2021 | Dec 31, 2021 | $4.33B | +27.3% |
| 2020 | Dec 31, 2020 | $3.41B | +150.6% |
| 2019 | Dec 31, 2019 | $1.36B | +2771.3% |
| 2018 | Dec 31, 2018 | $47.33M | – |
See a number that looks wrong?